Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Flk-1/KDR receptor tyrosine kinase inhibitor SU-5416 characterized at ACS meeting

April 9, 1998

EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing

April 9, 1998

Mitotix describes novel inhibitors of the CDK/cyclin complexes

April 9, 1998

Novel topoisomerase I inhibitor discovered at Kaken

April 8, 1998

Symphar antineoplastic agent induces apoptosis and reverses MDR

April 8, 1998

HER2 receptor tyrosine kinase inhibitors synthesized at Takeda

April 8, 1998

Zadaxin in combination with TACE shows promise in liver cancer therapy

April 8, 1998

Genta announces issue of patent for lead antisense compound

April 8, 1998

Orphan Medical announces results of Busulfex clinical trials

April 7, 1998

Novel apoptosis-related protease disclosed by Genetics Institute

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...